Pete Wishart MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
5 published records · newest first.
Written questions
Infected Blood Compensation SchemeCabinet OfficeTabled 26 Mar 2026AnsweredUIN 124056More
Question: To ask the Minister for the Cabinet Office, what considerations have been given to extending the cut-off date for eligibility for the Unethical Research Award in the Infected Blood Compensation Scheme beyond 1984, given the evidence in the Infected Blood
Answer: The Inquiry, in its Additional Report, made a set of recommendations about the Unethical Research awards. The Government has consulted on these recommendations, including on a proposal to expand eligibility for Unethical Research awards to all infected pe...
Answered 13 Apr 2026
Original Parliament recordInfected Blood Compensation SchemeCabinet OfficeTabled 26 Mar 2026AnsweredUIN 124055More
Question: To ask the Minister for the Cabinet Office, what justification is being applied to changes to the Infected Blood Compensation Scheme, where individuals who suffered long-term health harms of interferon treatment are to receive an uplift in compensation fr
Answer: The Inquiry recommended changes to the infection severity bands to give greater recognition for the suffering caused by interferon treatment. The Government agrees that changes are needed and we have consulted on our proposal to introduce a new infection ...
Answered 13 Apr 2026
Original Parliament recordInfected Blood Compensation Scheme: HepatitisCabinet OfficeTabled 26 Mar 2026AnsweredUIN 124054More
Question: To ask the Minister for the Cabinet Office, what consideration is being given to altering the Hepatitis C Financial Loss Award to reflect people who received older and more harmful treatments; and if he will make a statement.
Answer: In its Additional Report, the Infected Blood Inquiry recommended changes to the infection severity bands to give greater recognition for the suffering caused particularly by interferon treatment. The Government agrees that changes are needed and has consu...
Answered 13 Apr 2026
Original Parliament recordInfected Blood Compensation Scheme: HepatitisCabinet OfficeTabled 26 Mar 2026AnsweredUIN 124053More
Question: To ask the Minister for the Cabinet Office, if he will publish the grounds of justification for the reduction in hepatitis C Financial Loss Awards from 2017 due to the introduction of new effective treatments; and if he will make a statement.
Answer: The compensation scheme assumes that the introduction of effective treatments in 2016 improved most infected people’s ability to effectively manage their infection. This assumption is applied when calculating financial loss for living infected people.The ...
Answered 13 Apr 2026
Original Parliament recordDrugs: DeathCabinet OfficeTabled 10 Oct 2025AnsweredUIN 78015More
Question: To ask the Minister for the Cabinet Office, when the Government was first advised by the Office for National Statistics that the information provided by coroners on death registrations relating to drug deaths could lack detail on the specific drugs involv
Answer: The information requested falls under the remit of the UK Statistics Authority. A response to the Hon gentleman’s Parliamentary Question of 10th October is attached.
Answered 21 Oct 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
| Department or topic | Published records |
|---|---|
| Cabinet Office | 5 |
| Home Office | 13 |
| Scotland Office | 1 |
Published records only — not a full account of an MP’s work. How we work →